Cargando…
Brain and heart‐specific death in cancer patients: Population‐based study
BACKGROUND: The occurrence of cardiovascular events is a major cause of death in patients with cancer. Small studies have documented a connection between specific brain alterations and autonomic cardiac dysfunctions, possibly resulting in a worse prognosis. We aimed to refine the knowledge of fatal...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8419745/ https://www.ncbi.nlm.nih.gov/pubmed/34374226 http://dx.doi.org/10.1002/cam4.4069 |
_version_ | 1783748814133264384 |
---|---|
author | Safi, Mohammed Al‐Nusaif, Murad Trapani, Dario Mashrah, Mubarak A Kanesvaran, Ravindran Alzandani, Aziz Al‐Azab, Mahmoud Mazher, Syed A Al‐Danakh, Abdullah Liu, Jiwei |
author_facet | Safi, Mohammed Al‐Nusaif, Murad Trapani, Dario Mashrah, Mubarak A Kanesvaran, Ravindran Alzandani, Aziz Al‐Azab, Mahmoud Mazher, Syed A Al‐Danakh, Abdullah Liu, Jiwei |
author_sort | Safi, Mohammed |
collection | PubMed |
description | BACKGROUND: The occurrence of cardiovascular events is a major cause of death in patients with cancer. Small studies have documented a connection between specific brain alterations and autonomic cardiac dysfunctions, possibly resulting in a worse prognosis. We aimed to refine the knowledge of fatal cardiac events in patients with brain metastasis (BM). METHODS: We performed a Surveillance, Epidemiology, and End Results SEER registry‐based investigation (timeline: 2010–2016) and extracted all the advanced patients who had experienced fatal cardiac outcomes. Populations were compared according to the presence or not BM. Kaplan–Meier (KM) methodology was used for survival analysis and a multivariate model was developed by adjusting for multiple possible confounders. RESULTS: Most related BM and cardiac death were observed at the site of lung cancer (81.4%). We extracted 3187 patients with lung cancer site, including 417 patients who had experienced fatal heart‐specific with a history of BM, which is considered a BM group. The second group of heart‐specific death included 2770 patients was stated as a non‐BM group. Patients who had experienced heart‐specific death in the BM group were predominately male, right side, upper site, and non‐small type (62.11%, 54.92%, 51.56%, 69.78%), respectively. The survival outcomes between BM and the non‐ BM was significantly prominent (p = 0.003; median: 2 months vs. 3 months).The negative prognostic independent significance of heart‐fatal events was confirmed after adjusting for multiple variables (HR = 0.76, CI = 0.68–84, p < 0.0001). The metastatic liver site was significantly associated with poorer survival rates (HR = 0.68; CI = 0.52–0.88, p = 0.005). We revealed a possible connection between the brain and heart functions. CONCLUSIONS: The prognosis of heart‐specific death patients in BM is unfavorable compared to non‐BM settings in lung cancer. We may be at the gates of a new field of neurocardiooncology. |
format | Online Article Text |
id | pubmed-8419745 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-84197452021-09-08 Brain and heart‐specific death in cancer patients: Population‐based study Safi, Mohammed Al‐Nusaif, Murad Trapani, Dario Mashrah, Mubarak A Kanesvaran, Ravindran Alzandani, Aziz Al‐Azab, Mahmoud Mazher, Syed A Al‐Danakh, Abdullah Liu, Jiwei Cancer Med Clinical Cancer Research BACKGROUND: The occurrence of cardiovascular events is a major cause of death in patients with cancer. Small studies have documented a connection between specific brain alterations and autonomic cardiac dysfunctions, possibly resulting in a worse prognosis. We aimed to refine the knowledge of fatal cardiac events in patients with brain metastasis (BM). METHODS: We performed a Surveillance, Epidemiology, and End Results SEER registry‐based investigation (timeline: 2010–2016) and extracted all the advanced patients who had experienced fatal cardiac outcomes. Populations were compared according to the presence or not BM. Kaplan–Meier (KM) methodology was used for survival analysis and a multivariate model was developed by adjusting for multiple possible confounders. RESULTS: Most related BM and cardiac death were observed at the site of lung cancer (81.4%). We extracted 3187 patients with lung cancer site, including 417 patients who had experienced fatal heart‐specific with a history of BM, which is considered a BM group. The second group of heart‐specific death included 2770 patients was stated as a non‐BM group. Patients who had experienced heart‐specific death in the BM group were predominately male, right side, upper site, and non‐small type (62.11%, 54.92%, 51.56%, 69.78%), respectively. The survival outcomes between BM and the non‐ BM was significantly prominent (p = 0.003; median: 2 months vs. 3 months).The negative prognostic independent significance of heart‐fatal events was confirmed after adjusting for multiple variables (HR = 0.76, CI = 0.68–84, p < 0.0001). The metastatic liver site was significantly associated with poorer survival rates (HR = 0.68; CI = 0.52–0.88, p = 0.005). We revealed a possible connection between the brain and heart functions. CONCLUSIONS: The prognosis of heart‐specific death patients in BM is unfavorable compared to non‐BM settings in lung cancer. We may be at the gates of a new field of neurocardiooncology. John Wiley and Sons Inc. 2021-08-10 /pmc/articles/PMC8419745/ /pubmed/34374226 http://dx.doi.org/10.1002/cam4.4069 Text en © 2021 The Authors. Cancer Medicine published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Clinical Cancer Research Safi, Mohammed Al‐Nusaif, Murad Trapani, Dario Mashrah, Mubarak A Kanesvaran, Ravindran Alzandani, Aziz Al‐Azab, Mahmoud Mazher, Syed A Al‐Danakh, Abdullah Liu, Jiwei Brain and heart‐specific death in cancer patients: Population‐based study |
title | Brain and heart‐specific death in cancer patients: Population‐based study |
title_full | Brain and heart‐specific death in cancer patients: Population‐based study |
title_fullStr | Brain and heart‐specific death in cancer patients: Population‐based study |
title_full_unstemmed | Brain and heart‐specific death in cancer patients: Population‐based study |
title_short | Brain and heart‐specific death in cancer patients: Population‐based study |
title_sort | brain and heart‐specific death in cancer patients: population‐based study |
topic | Clinical Cancer Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8419745/ https://www.ncbi.nlm.nih.gov/pubmed/34374226 http://dx.doi.org/10.1002/cam4.4069 |
work_keys_str_mv | AT safimohammed brainandheartspecificdeathincancerpatientspopulationbasedstudy AT alnusaifmurad brainandheartspecificdeathincancerpatientspopulationbasedstudy AT trapanidario brainandheartspecificdeathincancerpatientspopulationbasedstudy AT mashrahmubaraka brainandheartspecificdeathincancerpatientspopulationbasedstudy AT kanesvaranravindran brainandheartspecificdeathincancerpatientspopulationbasedstudy AT alzandaniaziz brainandheartspecificdeathincancerpatientspopulationbasedstudy AT alazabmahmoud brainandheartspecificdeathincancerpatientspopulationbasedstudy AT mazhersyeda brainandheartspecificdeathincancerpatientspopulationbasedstudy AT aldanakhabdullah brainandheartspecificdeathincancerpatientspopulationbasedstudy AT liujiwei brainandheartspecificdeathincancerpatientspopulationbasedstudy |